Home / Inspections / 1099074

FDA Inspection 1099074 — Octapharma Plasma, Inc.

Octapharma Plasma, Inc. — FEI 1053485

The FDA completed an inspection of Octapharma Plasma, Inc. on July 3, 2019 in Charlotte, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 3, 2019
Fiscal Year
2019
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Charlotte, NC (United States)

Facility

Other inspections at this facility

  • 1292178 (NAI Thu Nov 06 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1215163 (NAI Fri Jul 21 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1083437 (NAI Fri Mar 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 633306 (VAI Thu Dec 03 2009 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources